Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010

NCT03309670 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 660

Last updated 2019-02-04

No results posted yet for this study

Summary

The emergence of adult psychic disorders occurs in about three quarters of cases before 25 years. The Pass-Aje service of Clermont-Ferrand University Hospital is a psychiatric unit specializing in the management of disorders of young adults. This unit evaluates the first episodes among the diversity of the clinical presentations of the psychic disorders. Suicidal attempts or ideations account for a large part of the reasons for entering the unit and are found transversely in many disorders. Among the reasons for hospitalization are a wide variety of situations that are not initially associated with an accurate diagnosis such as withdrawal, de-schooling, runaways, behavioral disorders (disorders of social interactions, self and hetero aggression, eating disorders).

Investigator propose to study the psychiatric outcome of hospitalized patients in the Pass-Aje unit and their psychosocial evolution in order to compare them with the data of the general population and to identify the factors influencing their future.

Conditions

  • Psychiatry

Interventions

OTHER

Psychiatric future

Former young psychiatric patients are contacted to determine their psychiatric outcome.

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Eve COURTY · University Hospital, Clermont-Ferrand

Eligibility

Min Age
23 Years
Max Age
36 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-14
Primary Completion
2017-09-15
Completion
2019-05-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03309670 on ClinicalTrials.gov